INIT Relative Valuation - Initiator Pharma A/S - Alpha Spread
I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 7.35 SEK -2% Market Closed
Market Cap: 388.9m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of INIT.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INIT Relative Value
Base Case
Not Available
I
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.7
Forward
1.9
vs History
vs Industry
Median 3Y
-10.2
Median 5Y
-17.9
Industry
23.9
Forward
2.8
vs History
vs Industry
Median 3Y
-8.4
Median 5Y
-19.7
Industry
22.2
vs History
vs Industry
Median 3Y
-10.1
Median 5Y
-19.1
Industry
24
vs History
20
vs Industry
6
Median 3Y
13.1
Median 5Y
7.1
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.4
Forward
1.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.5
vs History
vs Industry
Median 3Y
-9.7
Median 5Y
-16.3
Industry
5.1
Forward
4.5
vs History
vs Industry
Median 3Y
-9.7
Median 5Y
-16.3
Industry
4.7
Forward
4.5
vs History
vs Industry
Median 3Y
-7.9
Median 5Y
-18.7
Industry
6.6
vs History
vs Industry
Median 3Y
-7.9
Median 5Y
-18.7
Industry
4.7
vs History
31
vs Industry
5
Median 3Y
48.9
Median 5Y
27.2
Industry
4.7

Multiples Across Competitors

INIT Competitors Multiples
Initiator Pharma A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Initiator Pharma A/S
STO:INIT
412m SEK 0 -16 -14.2 -14.2
US
Abbvie Inc
NYSE:ABBV
341.9B USD 6.2 64.6 15.8 24.1
US
Amgen Inc
NASDAQ:AMGN
180.5B USD 5.8 57.7 20.2 36.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
129B USD 9.6 29.8 26.2 29
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.6B USD 12 -252.2 26.8 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
104.5B USD 3.8 99.3 9.4 12
US
Epizyme Inc
F:EPE
94.1B EUR 1 981.8 -505.7 -550.7 -536
AU
CSL Ltd
ASX:CSL
142.3B AUD 6.5 36.7 22.4 28
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.5 -63 -56.9
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.4B USD 15.1 -485.3 213.7 328.9
P/E Multiple
Earnings Growth
DK
I
Initiator Pharma A/S
STO:INIT
Average P/E: 57.6
Negative Multiple: -16
N/A
US
Abbvie Inc
NYSE:ABBV
64.6
406%
US
Amgen Inc
NASDAQ:AMGN
57.7
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.8
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -252.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
99.3
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
AU
CSL Ltd
ASX:CSL
36.7
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -485.3 N/A
EV/EBITDA Multiple
EBITDA Growth
DK
I
Initiator Pharma A/S
STO:INIT
Average EV/EBITDA: 47.8
Negative Multiple: -14.2
N/A
US
Abbvie Inc
NYSE:ABBV
15.8
28%
US
Amgen Inc
NASDAQ:AMGN
20.2
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26.2
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.8
39%
US
Gilead Sciences Inc
NASDAQ:GILD
9.4
10%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -550.7 N/A
AU
CSL Ltd
ASX:CSL
22.4
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -63 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 185.3 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
213.7
N/A
EV/EBIT Multiple
EBIT Growth
DK
I
Initiator Pharma A/S
STO:INIT
Average EV/EBIT: 69.5
Negative Multiple: -14.2
N/A
US
Abbvie Inc
NYSE:ABBV
24.1
86%
US
Amgen Inc
NASDAQ:AMGN
36.6
95%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
12
26%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -536 N/A
AU
CSL Ltd
ASX:CSL
28
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.9 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 173.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
328.9
N/A

See Also

Discover More
Back to Top